These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia. Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033 [TBL] [Abstract][Full Text] [Related]
10. First line chemotherapy in low risk gestational trophoblastic neoplasia. Alazzam M; Tidy J; Hancock BW; Osborne R Cochrane Database Syst Rev; 2009 Jan; (1):CD007102. PubMed ID: 19160319 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for high-risk gestational trophoblastic tumour. Deng L; Yan X; Zhang J; Wu T Cochrane Database Syst Rev; 2009 Apr; (2):CD005196. PubMed ID: 19370618 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy for gestational trophoblastic neoplasia patients with a FIGO score of 12 or greater: A multistudy analysis. Li J; Yue H; Wang X; Chen R; Lu X Eur J Obstet Gynecol Reprod Biol; 2019 Jul; 238():164-169. PubMed ID: 31136884 [TBL] [Abstract][Full Text] [Related]
16. Treatment of extremely high risk and resistant gestational trophoblastic neoplasia patients in King Chulalongkorn Memorial Hospital. Oranratanaphan S; Lertkhachonsuk R Asian Pac J Cancer Prev; 2014; 15(2):925-8. PubMed ID: 24568520 [TBL] [Abstract][Full Text] [Related]
17. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India. Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171 [TBL] [Abstract][Full Text] [Related]
18. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen. Mao Y; Wan X; Lv W; Xie X Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633 [TBL] [Abstract][Full Text] [Related]
19. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis. Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709 [TBL] [Abstract][Full Text] [Related]
20. Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia. Rattanaburi A; Boonyapipat S; Supasinth Y Asian Pac J Cancer Prev; 2015; 16(12):5037-41. PubMed ID: 26163637 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]